Shared Decision-making for Biologic Treatment of Autoimmune Disease: Influence on Adherence, Persistence, Satisfaction, and Health Care Costs

Overview

Journal Patient Prefer Adherence

Date 2017 Jun 3

PMID 28572722

Citations 38

Authors

Jennifer H Lofland

Phaedra T Johnson

Mike P Ingham

Sarah C Rosemas

John C White

Lorie Ellis

Affiliations

Soon will be listed here.

Abstract

Background: Shared decision-making (SDM), a process whereby physicians and patients collaborate to select interventions, is not well understood for biologic treatment of autoimmune conditions.

Methods: This was a cross-sectional survey of adults initiating treatment for Crohn's disease or ulcerative colitis (inflammatory bowel disease, IBD) or psoriatic arthritis or rheumatoid arthritis (RA/PA). Survey data were linked to administrative claims for 6 months before (baseline) and after (follow-up) therapy initiation. Measures included the Shared Decision Making Questionnaire, Patient Activation Measure (PAM), Morisky Medication Adherence Scale (MMAS), general health, and treatment satisfaction. Claims-based Quan-Charlson comorbidity scores, persistence, medication possession ratio (MPR), and health care costs were examined. Patients were compared by participation (SDM) and nonparticipation (non-SDM) in SDM.

Results: Among 453 respondents, 357 were eligible, and 306 patients (204 RA/PA and 102 IBD) were included in all analyses. Overall (n=357), SDM participants (n=120) were more often females (75.0% vs 62.5%, =0.018), had lower health status (48.0 vs 55.4, =0.005), and higher Quan-Charlson scores (1.0 vs 0.7, =0.035) than non-SDM (n=237) participants. Lower MMAS scores (SDM 0.17 vs non-SDM 0.41; <0.05) indicated greater likelihood of adherence; SDM participants also reported higher satisfaction with medication and had greater activation (PAM: SDM vs non-SDM: 66.9 vs 61.6; <0.001). Mean MPR did not differ, but persistence was longer among SDM participants (111.2 days vs 102.2 days for non-SDM; =0.029). Costs did not differ by SDM status overall, or among patients with RA/PA. The patients with IBD, however, experienced lower (=0.003) total costs ($9,404 for SDM vs $25,071 for non-SDM) during follow-up.

Conclusion: This study showed greater likelihood of adherence and satisfaction for patients who engaged in SDM and reduced health care costs among patients with IBD who engaged in SDM. This study provides a basis for defining SDM participation and detecting differences by SDM participation for biologic treatment selection for autoimmune conditions.

Citing Articles

Implementation suggestions for shared decision-making: results from a comparative study of inpatients and outpatients experience surveys.

Tian C, Wong E, Qiu H, Liu S, Wang K, Wei Y BMC Health Serv Res. 2025; 25(1):362.

PMID: 40069780 PMC: 11895247. DOI: 10.1186/s12913-025-12507-0.

Understanding the therapeutic toolkit for inflammatory bowel disease.

Vieujean S, Jairath V, Peyrin-Biroulet L, Dubinsky M, Iacucci M, Magro F Nat Rev Gastroenterol Hepatol. 2025; .

PMID: 39891014 DOI: 10.1038/s41575-024-01035-7.

Romano F, Di Scipio F, Baima G, Franco F, Aimetti M, Berta G J Clin Med. 2025; 14(1.

PMID: 39797336 PMC: 11721659. DOI: 10.3390/jcm14010254.

Designing for medication adherence in inflammatory bowel disease: multi-disciplinary approaches for self-administrable biotherapeutics.

Feig V, Zhang S, Patel A, Santos B, Kang Z, Wasan S EClinicalMedicine. 2025; 77:102850.

PMID: 39763512 PMC: 11701474. DOI: 10.1016/j.eclinm.2024.102850.

Implementing and evaluating shared decision-making before transcatheter aortic valve implantation with a dedicated pathway and questionnaire.

Carulli E, Browne S, Woolley S, Tindale A, Pottle A, Nagle K Eur Heart J Open. 2024; 4(6):oeae095.

PMID: 39678759 PMC: 11643346. DOI: 10.1093/ehjopen/oeae095.

References

Simon D, Loh A, Harter M . Measuring (shared) decision-making--a review of psychometric instruments. Z Arztl Fortbild Qualitatssich. 2007; 101(4):259-67. DOI: 10.1016/j.zgesun.2007.02.029. View

Mathews A, Coleska A, Burns P, Chung K . Evolution of Patient Decision-Making Regarding Medical Treatment of Rheumatoid Arthritis. Arthritis Care Res (Hoboken). 2015; 68(3):318-24. PMC: 5079428. DOI: 10.1002/acr.22688. View

Simon D, Schorr G, Wirtz M, Vodermaier A, Caspari C, Neuner B . Development and first validation of the shared decision-making questionnaire (SDM-Q). Patient Educ Couns. 2006; 63(3):319-27. DOI: 10.1016/j.pec.2006.04.012. View

Umar N, Litaker D, Schaarschmidt M, Peitsch W, Schmieder A, Terris D . Outcomes associated with matching patients' treatment preferences to physicians' recommendations: study methodology. BMC Health Serv Res. 2012; 12:1. PMC: 3276415. DOI: 10.1186/1472-6963-12-1. View

Morisky D, Malotte C, Choi P, Davidson P, Rigler S, Sugland B . A patient education program to improve adherence rates with antituberculosis drug regimens. Health Educ Q. 1990; 17(3):253-67. DOI: 10.1177/109019819001700303. View

Arterburn D, Wellman R, Westbrook E, Rutter C, Ross T, McCulloch D . Introducing decision aids at Group Health was linked to sharply lower hip and knee surgery rates and costs. Health Aff (Millwood). 2012; 31(9):2094-104. DOI: 10.1377/hlthaff.2011.0686. View

Quan H, Li B, Couris C, Fushimi K, Graham P, Hider P . Updating and validating the Charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries. Am J Epidemiol. 2011; 173(6):676-82. DOI: 10.1093/aje/kwq433. View

Bewtra M, Reed Johnson F . Assessing patient preferences for treatment options and process of care in inflammatory bowel disease: a critical review of quantitative data. Patient. 2013; 6(4):241-55. PMC: 3865778. DOI: 10.1007/s40271-013-0031-2. View

Renzi C, Di Pietro C, Tabolli S . Participation, satisfaction and knowledge level of patients with cutaneous psoriasis or psoriatic arthritis. Clin Exp Dermatol. 2011; 36(8):885-8. DOI: 10.1111/j.1365-2230.2011.04126.x. View

10.

Hibbard J, Greene J . What the evidence shows about patient activation: better health outcomes and care experiences; fewer data on costs. Health Aff (Millwood). 2013; 32(2):207-14. DOI: 10.1377/hlthaff.2012.1061. View

11.

Siegel C, Lofland J, Naim A, Gollins J, Walls D, Rudder L . Novel Statistical Approach to Determine Inflammatory Bowel Disease: Patients' Perspectives on Shared Decision Making. Patient. 2015; 9(1):79-89. DOI: 10.1007/s40271-015-0126-z. View

12.

Morisky D, DiMatteo M . Improving the measurement of self-reported medication nonadherence: response to authors. J Clin Epidemiol. 2010; 64(3):255-7. PMC: 3109729. DOI: 10.1016/j.jclinepi.2010.09.002. View

13.

Greene J, Hibbard J . Why does patient activation matter? An examination of the relationships between patient activation and health-related outcomes. J Gen Intern Med. 2011; 27(5):520-6. PMC: 3326094. DOI: 10.1007/s11606-011-1931-2. View

14.

Ware Jr J, Sherbourne C . The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992; 30(6):473-83. View

15.

Cote-Daigneault J, Bouin M, Lahaie R, Colombel J, Poitras P . Biologics in inflammatory bowel disease: what are the data?. United European Gastroenterol J. 2015; 3(5):419-28. PMC: 4625751. DOI: 10.1177/2050640615590302. View

16.

Kriston L, Scholl I, Holzel L, Simon D, Loh A, Harter M . The 9-item Shared Decision Making Questionnaire (SDM-Q-9). Development and psychometric properties in a primary care sample. Patient Educ Couns. 2009; 80(1):94-9. DOI: 10.1016/j.pec.2009.09.034. View

17.

Conrad S, Huppe A, Raspe H . [Preference of patients with inflammatory bowel disease regarding information and shared decision-making: results from a cross-sectional survey in Germany]. Z Gastroenterol. 2012; 50(4):364-72. DOI: 10.1055/s-0031-1281949. View

18.

Lipstein E, Dodds C, Britto M . Real life clinic visits do not match the ideals of shared decision making. J Pediatr. 2014; 165(1):178-183.e1. PMC: 4106460. DOI: 10.1016/j.jpeds.2014.03.042. View

19.

Elwyn G, Lloyd A, May C, van der Weijden T, Stiggelbout A, Edwards A . Collaborative deliberation: a model for patient care. Patient Educ Couns. 2014; 97(2):158-64. DOI: 10.1016/j.pec.2014.07.027. View

20.

Elwyn G, Frosch D, Thomson R, Joseph-Williams N, Lloyd A, Kinnersley P . Shared decision making: a model for clinical practice. J Gen Intern Med. 2012; 27(10):1361-7. PMC: 3445676. DOI: 10.1007/s11606-012-2077-6. View